Clozapine-related obsessive–compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study

<p><strong>Background</strong></p> <p>Obsessive–compulsive symptoms (OCS) are commonly associated with clozapine treatment but are frequently overlooked by clinicians despite their potential impact on patients' quality of life. In this study, we explored whether OC...

Full description

Bibliographic Details
Main Authors: Parkin, K, Chen, S, Biria, M, Plaistow, J, Beckwith, H, Jarratt-Barnham, I, Segarra, N, Worbe, Y, Fineberg, NA, Cardinal, RN, Robbins, TW, Fernandez-Egea, E
Format: Journal article
Language:English
Published: Cambridge University Press 2022
_version_ 1797109818566115328
author Parkin, K
Chen, S
Biria, M
Plaistow, J
Beckwith, H
Jarratt-Barnham, I
Segarra, N
Worbe, Y
Fineberg, NA
Cardinal, RN
Robbins, TW
Fernandez-Egea, E
author_facet Parkin, K
Chen, S
Biria, M
Plaistow, J
Beckwith, H
Jarratt-Barnham, I
Segarra, N
Worbe, Y
Fineberg, NA
Cardinal, RN
Robbins, TW
Fernandez-Egea, E
author_sort Parkin, K
collection OXFORD
description <p><strong>Background</strong></p> <p>Obsessive–compulsive symptoms (OCS) are commonly associated with clozapine treatment but are frequently overlooked by clinicians despite their potential impact on patients' quality of life. In this study, we explored whether OCS severity impacted subjective wellbeing and general functioning, independently of depressive and psychotic symptoms.</p> <p><strong>Methods</strong></p> <p>We used anonymised electronic healthcare records from a large cohort of patients who were treated with clozapine and assessed annually for OCS, wellbeing, general functioning, and psychopathology using standardised scales as part of routine clinical practice. We used statistical mixed linear model techniques to evaluate the longitudinal influence of OCS severity on wellbeing and general functioning.</p> <p><strong>Results</strong></p> <p>A total of 184 patients were included, with 527 face-to-face assessments and 64.7% evaluated three or more times. Different linear mixed models demonstrated that OCS in patients treated with clozapine were associated with significantly worse wellbeing scores, independently of depression and psychotic symptoms, but OCS did not impair general functioning. Obsessional thinking and hoarding behaviour, but not compulsions, were significantly associated with the impact on wellbeing, which may be attributable to the ego-syntonic nature of the compulsions.</p> <p><strong>Conclusions</strong></p> <p>Given the frequent occurrence of OCS and their negative impact on wellbeing, we encourage clinicians to routinely assess and treat OCS in patients who are taking clozapine.</p>
first_indexed 2024-03-07T07:46:37Z
format Journal article
id oxford-uuid:374961c1-9a9e-4857-8420-30d4bdc34c13
institution University of Oxford
language English
last_indexed 2024-03-07T07:46:37Z
publishDate 2022
publisher Cambridge University Press
record_format dspace
spelling oxford-uuid:374961c1-9a9e-4857-8420-30d4bdc34c132023-06-19T09:15:02ZClozapine-related obsessive–compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:374961c1-9a9e-4857-8420-30d4bdc34c13EnglishSymplectic ElementsCambridge University Press 2022Parkin, KChen, SBiria, MPlaistow, JBeckwith, HJarratt-Barnham, ISegarra, NWorbe, YFineberg, NACardinal, RNRobbins, TWFernandez-Egea, E<p><strong>Background</strong></p> <p>Obsessive–compulsive symptoms (OCS) are commonly associated with clozapine treatment but are frequently overlooked by clinicians despite their potential impact on patients' quality of life. In this study, we explored whether OCS severity impacted subjective wellbeing and general functioning, independently of depressive and psychotic symptoms.</p> <p><strong>Methods</strong></p> <p>We used anonymised electronic healthcare records from a large cohort of patients who were treated with clozapine and assessed annually for OCS, wellbeing, general functioning, and psychopathology using standardised scales as part of routine clinical practice. We used statistical mixed linear model techniques to evaluate the longitudinal influence of OCS severity on wellbeing and general functioning.</p> <p><strong>Results</strong></p> <p>A total of 184 patients were included, with 527 face-to-face assessments and 64.7% evaluated three or more times. Different linear mixed models demonstrated that OCS in patients treated with clozapine were associated with significantly worse wellbeing scores, independently of depression and psychotic symptoms, but OCS did not impair general functioning. Obsessional thinking and hoarding behaviour, but not compulsions, were significantly associated with the impact on wellbeing, which may be attributable to the ego-syntonic nature of the compulsions.</p> <p><strong>Conclusions</strong></p> <p>Given the frequent occurrence of OCS and their negative impact on wellbeing, we encourage clinicians to routinely assess and treat OCS in patients who are taking clozapine.</p>
spellingShingle Parkin, K
Chen, S
Biria, M
Plaistow, J
Beckwith, H
Jarratt-Barnham, I
Segarra, N
Worbe, Y
Fineberg, NA
Cardinal, RN
Robbins, TW
Fernandez-Egea, E
Clozapine-related obsessive–compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study
title Clozapine-related obsessive–compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study
title_full Clozapine-related obsessive–compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study
title_fullStr Clozapine-related obsessive–compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study
title_full_unstemmed Clozapine-related obsessive–compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study
title_short Clozapine-related obsessive–compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study
title_sort clozapine related obsessive compulsive symptoms and their impact on wellbeing a naturalistic longitudinal study
work_keys_str_mv AT parkink clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT chens clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT biriam clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT plaistowj clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT beckwithh clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT jarrattbarnhami clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT segarran clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT worbey clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT finebergna clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT cardinalrn clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT robbinstw clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy
AT fernandezegeae clozapinerelatedobsessivecompulsivesymptomsandtheirimpactonwellbeinganaturalisticlongitudinalstudy